Total Payments
$158,497
2024 Payments
$64,960
Companies
15
Transactions
96
Medicare Patients
51
Medicare Billing
$9,812
Payment Breakdown by Category
Other$86,867 (54.8%)
Travel$34,155 (21.5%)
Consulting$33,712 (21.3%)
Food & Beverage$3,023 (1.9%)
Research$739.39 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $66,030 | 7 | 41.7% |
| Travel and Lodging | $34,155 | 30 | 21.5% |
| Consulting Fee | $33,712 | 10 | 21.3% |
| Honoraria | $20,837 | 4 | 13.1% |
| Food and Beverage | $3,023 | 43 | 1.9% |
| Unspecified | $739.39 | 2 | 0.5% |
Payments by Type
General
$157,758
94 transactions
Research
$739.39
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $83,643 | 25 | $0 (2024) |
| CSL Behring | $25,674 | 14 | $0 (2022) |
| GENZYME CORPORATION | $14,444 | 8 | $0 (2020) |
| Shire North American Group Inc | $12,355 | 10 | $0 (2019) |
| Regeneron Pharmaceuticals, Inc. | $9,572 | 13 | $0 (2022) |
| Octapharma USA, Inc. | $6,589 | 2 | $0 (2024) |
| Genentech, Inc. | $2,925 | 1 | $0 (2020) |
| SANOFI US SERVICES INC. | $2,091 | 1 | $0 (2020) |
| Veloxis Pharmaceuticals, Inc. | $365.18 | 2 | $0 (2022) |
| One Lambda, Inc. | $284.83 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64,960 | 17 | SANOFI-AVENTIS U.S. LLC ($58,253) |
| 2022 | $26,635 | 15 | SANOFI-AVENTIS U.S. LLC ($21,782) |
| 2021 | $5,707 | 5 | SANOFI-AVENTIS U.S. LLC ($3,609) |
| 2020 | $25,004 | 14 | GENZYME CORPORATION ($14,444) |
| 2019 | $30,065 | 27 | CSL Behring ($16,289) |
| 2018 | $6,033 | 11 | CSL Behring ($5,921) |
| 2017 | $94.18 | 7 | PFIZER INC. ($94.18) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $15,488.00 | General |
| Category: Oncology | ||||||
| 10/01/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Travel and Lodging | In-kind items and services | $898.44 | General |
| Category: Oncology | ||||||
| 10/01/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Travel and Lodging | Cash or cash equivalent | $220.19 | General |
| Category: Oncology | ||||||
| 10/01/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Travel and Lodging | In-kind items and services | $195.00 | General |
| Category: Oncology | ||||||
| 10/01/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Food and Beverage | In-kind items and services | $138.79 | General |
| Category: Oncology | ||||||
| 09/28/2024 | Octapharma USA, Inc. | WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) | Travel and Lodging | Cash or cash equivalent | $6,171.00 | General |
| Category: COAGULATION | ||||||
| 09/28/2024 | Octapharma USA, Inc. | WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) | Travel and Lodging | Cash or cash equivalent | $417.70 | General |
| Category: COAGULATION | ||||||
| 06/28/2024 | SANOFI-AVENTIS U.S. LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,250.00 | General |
| 06/28/2024 | SANOFI-AVENTIS U.S. LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| 06/27/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $21,525.00 | General |
| Category: Oncology | ||||||
| 06/27/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $10,332.20 | General |
| Category: Oncology | ||||||
| 06/27/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $593.82 | General |
| Category: Oncology | ||||||
| 06/27/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | Cash or cash equivalent | $308.01 | General |
| Category: Oncology | ||||||
| 06/27/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $292.84 | General |
| Category: Oncology | ||||||
| 06/27/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $231.38 | General |
| Category: Oncology | ||||||
| 06/27/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | Cash or cash equivalent | $153.91 | General |
| Category: Oncology | ||||||
| 02/23/2024 | Paragonix Technologies, Inc. | SherpaPak (Device), LiverGuard, LungGuard | Food and Beverage | In-kind items and services | $118.69 | General |
| Category: Cardiology | ||||||
| 12/01/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $3,463.75 | General |
| 11/03/2022 | Regeneron Pharmaceuticals, Inc. | — | — | In-kind items and services | $451.48 | Research |
| Study: REGN5458 Clinical Development Program | ||||||
| 09/07/2022 | One Lambda, Inc. | — | Food and Beverage | Cash or cash equivalent | $284.83 | General |
| 08/12/2022 | Regeneron Pharmaceuticals, Inc. | — | — | In-kind items and services | $287.91 | Research |
| Study: REGN5458 Clinical Development Program | ||||||
| 05/20/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $222.58 | General |
| Category: Immunosuppresant | ||||||
| 05/20/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | Cash or cash equivalent | $142.60 | General |
| Category: Immunosuppresant | ||||||
| 04/06/2022 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $14,808.00 | General |
| Category: Oncology | ||||||
| 04/06/2022 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Consulting Fee | Cash or cash equivalent | $2,178.00 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| REGN5458 Clinical Development Program | Regeneron Pharmaceuticals, Inc. | $739.39 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 11 | $11,715 | $2,031 |
| 2022 | 1 | 11 | 11 | $11,715 | $2,177 |
| 2021 | 1 | 16 | 16 | $17,040 | $3,428 |
| 2020 | 1 | 13 | 13 | $13,845 | $2,176 |
Total Patients
51
Total Services
51
Medicare Billing
$9,812
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $11,715 | $2,031 | 17.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $11,715 | $2,177 | 18.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $17,040 | $3,428 | 20.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 13 | 13 | $13,845 | $2,176 | 15.7% |
About Dr. Robert Montgomery, M.D
Dr. Robert Montgomery, M.D is a Surgery healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467404137.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Montgomery, M.D has received a total of $158,497 in payments from pharmaceutical and medical device companies, with $64,960 received in 2024. These payments were reported across 96 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($66,030).
As a Medicare-enrolled provider, Montgomery has provided services to 51 Medicare beneficiaries, totaling 51 services with total Medicare billing of $9,812. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgery
- Other Specialties Surgery, Transplant Surgery
- Location Baltimore, MD
- Active Since 05/17/2006
- Last Updated 05/16/2024
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1467404137
Products in Payments
- THYMOGLOBULIN (Biological) $69,663
- REZUROCK (Drug) $16,940
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) $6,589
- Non-Covered Product (Drug) $2,925
- Envarsus (Drug) $365.18
- CHANTIX (Drug) $151.34
- SherpaPak (Device) $118.69
- VIAGRA (Drug) $43.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Baltimore
Dorry Segev, M.d, M.D
Surgery — Payments: $1.3M
Surgery $1.3M
Thomas Swope, Md, MD
Surgery — Payments: $1.1M
Surgery $1.1M
Dr. Alisa Coker, M.d, M.D
Surgery — Payments: $608,746
Surgery $608,746
Dr. John Ledonne, M.d, M.D
Surgery — Payments: $514,756
Surgery $514,756
Dr. Christopher You, M.d, M.D
Surgery — Payments: $134,200
Surgery $134,200
Martin Makary, M.d., M.p.h, M.D., M.P.H
Surgery — Payments: $130,421
Surgery $130,421